Fresenius Medical Care Stock Forecast
NYSE: FMSHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
FMS analyst consensus
Consensus (7 analysts)
hold
Avg. price target
$23.43+12.21%
- Strong buy 1
- Buy 0
- Hold 3
- Sell 1
- Strong sell 2
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering Fresenius Medical Care (2026-10-07), 1 rate the stock a buy or strong buy, 3 rate it a hold and 3 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $23.43, with a high estimate of $36.99 and a low estimate of $16.81. The average target implies upside of 12.2% from the current price of $20.88.
The spread between the highest and lowest targets is 120.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for FMS.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 14% |
| Buy | 0 | 0% |
| Hold | 3 | 43% |
| Sell | 1 | 14% |
| Strong sell | 2 | 29% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $16.81 | -19.49% |
| Average target | $23.43 | +12.21% |
| High target | $36.99 | +77.16% |